A series of new liquid crystalline compounds with BCH- and CBC- structures was synthesized. They differ from the known carbocyclic analogs by the 1,2,4-oxadiazole fragment placed in various positions of the long mesomorphic molecule. The cross-coupling reaction of the aromatic boric acids and bromides is a new way for mesogenic heterocycles design. The transition temperatures of these new liquid crystals are lower as compared with carbocyclic BCH- and CBC- analogs and significantly depend on the position of the nonlinear heterocyclic unit in the molecular chain.
No takes yet. Share an insight, caveat, or question.
Karamysheav et al. (1999) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: